How insulin signaling helps protect against urinary tract infections in people with diabetes
Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility
This study is looking at how insulin helps people with diabetes better fight off urinary tract infections (UTIs) by boosting their bladder's defenses, and it hopes to find new ways to prevent and treat these infections for those living with diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-10894255 on NIH RePORTER |
What this research studies
This research investigates the role of insulin signaling in enhancing the body's defenses against urinary tract infections (UTIs) in individuals with diabetes. It aims to understand how insulin affects the bladder's ability to fight off infections by regulating immune responses and strengthening the protective barrier of the bladder lining. By examining specific molecular targets, such as PPARγ and histone deacetylase proteins, the study seeks to identify new strategies for preventing and treating UTIs in diabetic patients. The findings could lead to improved therapies that bolster the innate immune system in the urinary tract.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with diabetes who are at risk for urinary tract infections.
Not a fit: Patients without diabetes or those who do not experience urinary tract infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new prevention and treatment strategies for urinary tract infections in patients with diabetes.
How similar studies have performed: Previous research has shown promising results in understanding the role of insulin in immune responses, suggesting that this approach may yield valuable insights.
Where this research is happening
Columbus, United States
- Research Inst Nationwide Children's Hosp — Columbus, United States (Active)
Researchers
- Principal investigator: Spencer, John David — Research Inst Nationwide Children's Hosp
- Study coordinator: Spencer, John David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.